| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | TNFRSF13B | Synonyms | CD267, CVID, CVID2, IGAD2, RYZN, TACI, TNFRSF14B | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p11.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | TNF receptor superfamily member 13B | ||||
| GTO ID | GTC1786 |
| Trial ID | NCT03287804 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA|TACI |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | APRIL CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma |
| Year | 2017 |
| Country | United Kingdom |
| Company sponsor | Autolus Limited |
| Other ID(s) | AUTO2-MM1|2016-003893-42 |
| Cohort 1 | |||||||||||||
|
|||||||||||||